ClinicalTrialsFinder
RecruitingNCT06167356

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).

Sponsor

IRCCS San Raffaele

Enrollment

20,000 participants

Start Date

Nov 27, 2013

Study Type

OBSERVATIONAL

Conditions

Bladder CancerBladder NeoplasmNon Muscle Invasive Bladder CancerBladder DiseaseBladder Urothelial CarcinomaNon-Muscle Invasive Bladder NeoplasmsNon-Muscle Invasive Bladder Urothelial CarcinomaBladder Cancer Stage I, With Cancer in SituBladder Cancer RecurrentBladder Urothelial Carcinoma in SituBladder Urothelial Dysplasia

Summary

A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • years or older
  • Patients with non-muscle invasive bladder cancer
  • Indication to cancer removal through endoscopic resection surgery
  • Ability to read and sign the informed consent

Exclusion Criteria2

  • Age \<18 years
  • Inability to read and sign the informed consent

Locations(1)

IRCCS Ospedale San Raffaele

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06167356

Related Trials

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT000268841 location

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582113 locations

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

NCT0712999379 locations

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

NCT0697316127 locations

Bio Clinical Collection of Urothelial Carcinoma

NCT049704721 location